Dr. Xiaoguang (Margaret) Liu, an Associate Professor in Department of Biomedical Engineering, recently received notice of award for four grants on which she is a collaborator, to conduct cancer research.

They include:

  • NIH MPI R01 to develop novel targeted therapy for triple negative breast cancer treatment by collaborating with Dr. Runa Liu in the Department of Genetics.
  • NIH MPI R01 grant to characterize a new biological factor for breast cancer racial disparities by collaborating with Dr. Lizhong Wang/Dr. Runa Liu in the Department of Genetics.
  • NIH MPI R21 to develop targeted therapy to treat neuroendocrine tumor by collaborating with Dr. Renata Jaskula-Sztul in the Department of Surgery.
  • Small Business Innovation Research subcontract to develop a novel biomanufacturing platform of targeting delivery vehicle of adeno-associated virus (AAV)-based gene therapy for cancer treatment by collaborating with Technology Commercialization Partners.

Benefiting from Margaret’s seven-year biopharmaceutical industrial experiences, solid support from the Department of Biomedical Engineering, and the robust research environment at UAB, the Liu Lab has developed several targeted therapies (monoclonal antibodies, antibody-drug conjugates, and gene therapies) and targeting delivery vehicle to treat cancers. Her lab aims to develop multiple novel anti-cancer therapies and move forward to clinical trial, which could benefit cancer patients in future.

More News

2020: The year in photos

2020: The year in photos

Each year, UAB’s official photographers capture tens of thousands of images as they document the incredible variety of events and personalities that make up our community. Here are some of our favorite photos of some of the most dramatic months in UAB history.

Read More